FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

July 31 2018 A class 3 recall for sodium cromoglicate 2% w/v eye drops and Murine Hayfever Relief...

Effect of omega-3 on heart disease is negligible, finds Cochrane review

Effect of omega-3 on heart disease is negligible, finds Cochrane review

July 19 2018 Cochrane researchers have published research indicating that omega 3 supplements...

BLF highlights decline in stop smoking prescriptions

BLF highlights decline in stop smoking prescriptions

July 18 2018 There has been a 75% decline in stop smoking treatments being prescribed by GPs and...

Welsh National Survey includes OTC medicine purchases for first time

Welsh National Survey includes OTC medicine purchases for first time

June 28 2018 Over half the population in Wales has reported having bought an over the counter...

Recall issued for several own label glycerine and blackcurrant cough syrups

Recall issued for several own label glycerine and blackcurrant cough syrups

June 20 2018 A Class 2 Drug Recall has been issued for 15 batches of own-brand children’s...

  • FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

    FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

    Tuesday, 31 July 2018 15:24
  • Effect of omega-3 on heart disease is negligible, finds Cochrane review

    Effect of omega-3 on heart disease is negligible, finds Cochrane review

    Thursday, 19 July 2018 10:21
  • BLF highlights decline in stop smoking prescriptions

    BLF highlights decline in stop smoking prescriptions

    Wednesday, 18 July 2018 17:32
  • Welsh National Survey includes OTC medicine purchases for first time

    Welsh National Survey includes OTC medicine purchases for first time

    Thursday, 28 June 2018 16:55
  • Recall issued for several own label glycerine and blackcurrant cough syrups

    Recall issued for several own label glycerine and blackcurrant cough syrups

    Wednesday, 20 June 2018 18:29

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

NanoReproAG logo450

NanoRepro AG is an innovative leader in development, manufacturing and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use, in the domestic and international markets. Since October 2008, NanoRepro has been publicly listed with its headquarters located in Marburg, Germany.

Our goal is to provide accuracy in self-diagnostics for rapid disease detection.

Self-diagnostics is a fast growing market shaped by the ever-increasing health conscious of the population and healthcare spending. Our rapid diagnostic tests offer significant advantages over all available competitive products due to our flexibility in product design, in-depth market understanding and best practices of just-in-time manufacturing. Our most important success factor is continuous optimization of manufacturing costs. We create values for our customers, shareholders and employees.

The company has currently 20 rapid diagnostic tests within the portfolio addressing various healthcare needs (family planning, preventive healthcare, allergies, infectious diseases, and point of care).

Products intended for home-use

OvuQuick250

 

 

 

OvuQUICK

GraviQUICK

 

GlutenCHECK

CholesterinCHECK

FertiQuick

 

 

 

 

 

 

 

FertiQUICK

VagiQUICK

 

 

 

VagiQUICK

MenoQUICK

GraviQUICK Frühtest

FOBCHECK

Heli C CHECK

 

 

 

 

Heli-C-CHECK

AlkoholTEST

MilkCHECK

AllergoCHECK

EierCHECK

Food Supplements Alphabiol Fertility, Alphabiol Pregnancy, Alphabiol Hair Plus, Alphabiol Skin & Hair, Alphabiol Cranberry, Alphabiol Menopause

 

B2B Products:

HIV-QUICK

Troponin I Test, Strep A-Test, Influenza A/B Test, Albumin Dipstick-Tube Test, D-Dimer Test

Philosophy and Vision

NanoRepro AG aims to provide the modern innovative rapid diagnostic tests of high-quality for the preventive health-care of every person. We belong to the leading German manufacturers in the sector of self-diagnostics.

In today's world there is an increasing interest in rapid diagnostic tests, and so the demand for such products is growing continuously. The steady raise of this medical market segment is expected in the future.

NanoRepro´s strong and experienced management and partner team ensures innovation strength, product quality and delivery security. Our employees are professionally trained in their field and thus, contribute to the success of the company. In order to meet the high quality requirements, our scientists are working closely with the institutions such as Philipps University of Marburg and Technical University of Munich. In terms of production, the company has a strong and exclusive strategic partnership with a highly experienced German manufacturer specialized in the field of rapid diagnostic tests. With regard to product design and marketing, we ensure maximum flexibility and short time to market. One of our key success factors is the continuous optimization of production costs.

NanoRepro AG is a highly interesting trade partner in regard to the possibility for the exclusive right of sales agreement.

NanoRepro AG aims to create an ever-growing value for its customers, shareholders and employees.

 

Management Board
Lisa Jüngst, CEO

Lisa Jüngst has been within works at NanoRepro AG since 2006. In April 2013, she was elected to the Board of Directors, and prior to that she had been responsible for the marketing, finance and personnel department as well as investor relations. In 2006, Lisa Jüngst was the first employee of the company, and so she brought the first rapid test of NanoRepro AG to market.

Lisa Jüngst studied business management at the University of Fulda. In 2006 she successfully graduated from the university with a degree in business administration. In addition, Lisa Jüngst is a member of the Young Entrepreneurs Alliance.

Please contact us, if you have any questions

NanoRepro AG
Untergasse 8
35037 Marburg
Tel.: +49 (0)6421 – 95 14 49
Fax: +49 (0)6421 – 95 14 51
E-Mail:
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.nano.ag

OTC News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...